Nephrostomy devices market seen reaching $1.89 billion by 2030

The Business Research Company says the nephrostomy devices market is set to grow from $1.3 billion in 2025 to $1.41 billion in 2026, then to $1.89 billion by 2030. The report points to rising kidney transplants, minimally invasive urology use and aging populations as key demand drivers.

Why it matters: - The nephrostomy devices market is expanding because hospitals and surgeons need more tools to manage blocked urinary flow and protect kidney function. - Rising use of kidney transplant care, minimally invasive procedures and long-term urinary drainage is expected to keep demand growing through 2030.

What happened: - The Business Research Company released its "Nephrostomy Devices Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report estimates the market will rise from $1.3 billion in 2025 to $1.41 billion in 2026. - The report forecasts the market will reach $1.89 billion by 2030. - The company published a free sample of the report at Download a free sample of the nephrostomy devices market report. - The company also made the full report available at View the full nephrostomy devices market report.

The details: - The 2025 to 2026 increase implies 8.4% compound annual growth. - The report links recent growth to higher prevalence of kidney stones, more urinary tract obstructions, more urological surgeries, expansion of hospital interventional radiology services and greater awareness of kidney preservation. - Nephrostomy devices create an artificial channel between the kidney and the skin so urine can drain. - The devices are used to manage kidney stones, tumors or strictures that block normal urinary flow. - The devices can provide temporary or long-term drainage while supporting kidney health and function. - The forecast period growth is driven by more urological cancer cases, wider use of minimally invasive urology, a growing elderly population with kidney disorders, more ambulatory surgical centers and stronger demand for long-term urinary drainage. - The report highlights a surge in percutaneous nephrostomy procedures, preference for minimally invasive drainage devices, broader use of hydrophilic and coated products, more image-guided interventions and a greater focus on patient comfort and infection control. - The report says kidney transplant procedures are a major growth driver because nephrostomy devices can help manage urinary tract complications during recovery. - The Organ Procurement and Transplantation Network reported 27,759 kidney transplants in the U.S. in 2024, up 1.6% from 2023. - The same January 2025 update said heart transplants were nearly flat at 4,572 in 2024 versus 4,545 in 2023. - In 2025, North America held the largest share of the global market. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

Between the lines: - The report frames nephrostomy devices as a small but steadily expanding segment tied to broader shifts in urology, cancer care and transplant medicine. - North America’s lead reflects mature healthcare infrastructure, while Asia-Pacific’s faster growth suggests rising procedure volumes and broader adoption of medical technology.

What's next: - The market is projected to keep growing at a 7.5% CAGR through 2030. - Demand will likely track transplant volumes, aging demographics and adoption of less invasive drainage tools. - The Business Research Company is promoting the report through its expert contact channels and social media presence, including LinkedIn and the company's social profiles.